Anthony S. Murabito
Corporate Officer/Principal bei New Jersey Society of Health-System Pharmacists
Aktive Positionen von Anthony S. Murabito
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| New Jersey Society of Health-System Pharmacists | Corporate Officer/Principal | - | - |
| Pennsylvania Society of Health-System Pharmacists | Corporate Officer/Principal | - | - |
Karriereverlauf von Anthony S. Murabito
Ehemalige bekannte Positionen von Anthony S. Murabito
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | 01.01.2003 |
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1981 | 01.01.2000 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2011 | - |
| CUBIST PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2003 | - |
Ausbildung von Anthony S. Murabito
| University of the Sciences in Philadelphia | Undergraduate Degree |
| Widener University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
| New Jersey Society of Health-System Pharmacists | |
| Pennsylvania Society of Health-System Pharmacists |
- Börse
- Insiders
- Anthony S. Murabito
- Erfahrung
